Alpha DNA Investment Management’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-79
Closed -$4K 241
2021
Q1
$4K Buy
79
+17
+27% +$861 ﹤0.01% 401
2020
Q4
$5K Buy
+62
New +$5K 0.01% 362